Upcoming EventsMore >>
DateTitle
10/27/14
2:00 p.m. PT
Q3 2014 Amgen Earnings Conference Call
10/28/14
8:00 a.m.
through
10/28/14
12:00 p.m. ET
Amgen 2014 Business Review
LocationNew York, NY
Recent NewsMore >>
DateTitle 
10/23/14Amgen To Webcast 2014 Business Review Meeting On October 28
THOUSAND OAKS, Calif., Oct. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will hold its Business Review Meeting on Tuesday, Oct. 28, 2014, at the Conrad New York, 102 North End Avenue, New York City, beginning at 8 a.m. ET. In the meeting, Robert A. Bradway, chairman and chief executive officer, Sean E. Harper, M.D., executive vice president, Research and Development, Anthony C. Hooper, executive vice president, Global Commercial Operations, and David W. Meline, executive... 
Printer Friendly Version
10/23/14Amgen Announces Webcast of 2014 Third Quarter Financial Results
THOUSAND OAKS, Calif., Oct. 23, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will report its third quarter financial results on Monday, Oct. 27, 2014, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team. Live audio of the confer... 
Printer Friendly Version
10/21/14Amgen Statement Regarding Third Point Investment
THOUSAND OAKS, Calif., Oct. 21, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) issued the following statement with respect to media inquiries concerning Third Point LLC's equity position in Amgen: Amgen maintains an active, engaged dialogue with all shareholders. Amgen has always appreciated the perspectives of all of its shareholders, including Third Point, and welcomes constructive input toward our common goal of enhancing shareholder value.  Amgen's Board of Directors frequently receives input... 
Printer Friendly Version
10/17/14Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors
THOUSAND OAKS, Calif., Oct. 17, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of R. Sanders Williams, M.D., president of Gladstone Institutes and Gladstone's Robert W. and Linda L. Mahley Distinguished Professor.  "We are pleased to welcome Dr. Sandy Williams to the Amgen Board," said Robert A. Bradway, chairman and chief executive officer of Amgen. "Dr. Williams' deep and distinguished experience in academic medicine and his direct experience in our industry will... 
Printer Friendly Version
What's New
09/30/14
Download Documentation 2003 – 2013 EPS Reconciliation
08/07/14
Download Documentation Investor Insights Newsletter - Q2 2014
Investor Insights Newsletters
DateTitle
08/07/14
Download Documentation Investor Insights Newsletter - Q2 2014
04/30/14
Download Documentation Investor Insights Newsletter - Q1 2014
02/11/14
Download Documentation Investor Insights Newsletter - Q4 2013
10/31/13
Download Documentation Investor Insights Newsletter - Q3 2013

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.